Gastrointestinal blood loss in patients receiving acetylsalicylic acid or diftalone, a new antiinflammatory drug: a comparative evaluation.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002860:Chromium Radioisotopes; D004912:Erythrocytes; D005243:Feces / Q000032:analysis; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006571:Heterocyclic Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009780:Occult Blood
D000893:Anti-Inflammatory Agents; D002860:Chromium Radioisotopes; D006571:Heterocyclic Compounds; D001241:Aspirin